Nutriband Statistics
Total Valuation
Nutriband has a market cap or net worth of $43.52 million. The enterprise value is $38.22 million.
Important Dates
The next estimated earnings date is Tuesday, June 16, 2026, after market close.
| Earnings Date | Jun 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nutriband has 12.16 million shares outstanding. The number of shares has increased by 9.74% in one year.
| Current Share Class | 12.16M |
| Shares Outstanding | 12.16M |
| Shares Change (YoY) | +9.74% |
| Shares Change (QoQ) | +0.86% |
| Owned by Insiders (%) | 42.58% |
| Owned by Institutions (%) | 3.15% |
| Float | 5.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.89 |
| Forward PS | n/a |
| PB Ratio | 6.52 |
| P/TBV Ratio | 8.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.36 |
| Quick Ratio | 5.98 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -369.11 |
Financial Efficiency
Return on equity (ROE) is -125.56% and return on invested capital (ROIC) is -76.79%.
| Return on Equity (ROE) | -125.56% |
| Return on Assets (ROA) | -69.23% |
| Return on Invested Capital (ROIC) | -76.79% |
| Return on Capital Employed (ROCE) | -122.98% |
| Weighted Average Cost of Capital (WACC) | 14.82% |
| Revenue Per Employee | $156,665 |
| Profits Per Employee | -$2.31M |
| Employee Count | 13 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 8.91 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.23% in the last 52 weeks. The beta is 1.93, so Nutriband's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | -56.23% |
| 50-Day Moving Average | 3.76 |
| 200-Day Moving Average | 5.03 |
| Relative Strength Index (RSI) | 47.60 |
| Average Volume (20 Days) | 10,398 |
Short Selling Information
The latest short interest is 185,933, so 1.53% of the outstanding shares have been sold short.
| Short Interest | 185,933 |
| Short Previous Month | 204,443 |
| Short % of Shares Out | 1.53% |
| Short % of Float | 3.52% |
| Short Ratio (days to cover) | 20.60 |
Income Statement
In the last 12 months, Nutriband had revenue of $2.04 million and -$30.04 million in losses. Loss per share was -$2.58.
| Revenue | 2.04M |
| Gross Profit | 566,308 |
| Operating Income | -8.32M |
| Pretax Income | -8.23M |
| Net Income | -30.04M |
| EBITDA | -8.12M |
| EBIT | -8.32M |
| Loss Per Share | -$2.58 |
Full Income StatementBalance Sheet
The company has $4.57 million in cash and $245,490 in debt, with a net cash position of $4.33 million or $0.36 per share.
| Cash & Cash Equivalents | 4.57M |
| Total Debt | 245,490 |
| Net Cash | 4.33M |
| Net Cash Per Share | $0.36 |
| Equity (Book Value) | 6.68M |
| Book Value Per Share | 0.55 |
| Working Capital | 4.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.13 million and capital expenditures -$5,324, giving a free cash flow of -$5.14 million.
| Operating Cash Flow | -5.13M |
| Capital Expenditures | -5,324 |
| Depreciation & Amortization | 193,797 |
| Net Borrowing | -21,617 |
| Free Cash Flow | -5.14M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
| Gross Margin | 27.81% |
| Operating Margin | -408.41% |
| Pretax Margin | -404.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nutriband does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.74% |
| Shareholder Yield | -9.74% |
| Earnings Yield | -70.61% |
| FCF Yield | -12.08% |
Analyst Forecast
The average price target for Nutriband is $15.00, which is 318.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 318.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | 297.17% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2022. It was a forward split with a ratio of 1.1666667:1.
| Last Split Date | Aug 12, 2022 |
| Split Type | Forward |
| Split Ratio | 1.1666667:1 |
Scores
Nutriband has an Altman Z-Score of 39.29 and a Piotroski F-Score of 3.
| Altman Z-Score | 39.29 |
| Piotroski F-Score | 3 |
